Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty

NCT03169231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Aging Frailty

Interventions

BIOLOGICAL: Longeveron Mesenchymal Stem Cells (LMSCs)
OTHER: Placebo

Sponsor

Longeveron Inc.